This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $147,917 to Brigham & Women's Hospital Inc. to conduct research on identifying cardiovascular disease risk in rheumatoid arthritis patients. The key objectives are to evaluate the use of high-sensitivity cardiac troponin as a biomarker to improve detection of coronary artery calcium and cardiovascular risk in a subgroup of rheumatoid arthritis patients, and to assess potential biases in AI algorithms developed using electronic health record data to identify rheumatoid arthritis and myocardial infarction populations. This 5-year award, starting on Jan 1, 2025, will support the training and career development of a mid-career physician scientist at Brigham & Women's Hospital, which is a subsidiary of the larger Partners Healthcare System organization. The research aims to advance clinical understanding and improve cardiovascular risk assessment for rheumatoid arthritis patients.
Generated 3/4/25, 6:16 AM